Risk of venous thromboembolism and major bleeding in the clinical course of osteosarcoma and Ewing sarcoma.
暂无分享,去创建一个
H. Gelderblom | A. Verschoor | H. Versteeg | M. A. van de Sande | F. Klok | M. Huisman | S. Cannegieter | F. Speetjens | M. A. Stals | M. V. D. van de Sande | F. Kaptein | R. E. Evenhuis | D. S. Karis | Renee W.D. Noten
[1] V. Tagalakis,et al. Efficacy and safety of apixaban for primary prevention of thromboembolism in patients with cancer and a central venous catheter: A subgroup analysis of the AVERT Trial. , 2022, Thrombosis research.
[2] M. Taphoorn,et al. Incidence and determinants of thrombotic and bleeding complications in patients with glioblastoma , 2022, Journal of thrombosis and haemostasis : JTH.
[3] H. Putter,et al. Estimation of the Absolute Risk of Cardiovascular Disease and Other Events: Issues With the Use of Multiple Fine-Gray Subdistribution Hazard Models , 2022, Circulation. Cardiovascular quality and outcomes.
[4] W. Mesker,et al. Incidence, timing and risk factors of venous thromboembolic events in patients with pancreatic cancer. , 2021, Thrombosis research.
[5] G. Raskob,et al. Abelacimab for Prevention of Venous Thromboembolism. , 2021, The New England journal of medicine.
[6] L. Soanes,et al. Adolescents and young adults (AYA) with cancer: a position paper from the AYA Working Group of the European Society for Medical Oncology (ESMO) and the European Society for Paediatric Oncology (SIOPE) , 2021, ESMO open.
[7] Lara A. Kahale,et al. American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer. , 2021, Blood advances.
[8] E. Horváth-Puhó,et al. Venous thromboembolism in cancer patients: a population-based cohort study. , 2020, Blood.
[9] T. Ozaki,et al. Symptomatic Venous Thromboembolism in Patients with Malignant Bone and Soft Tissue Tumors: A Prospective Multicenter Cohort Study , 2020, Annals of Surgical Oncology.
[10] G. Raskob,et al. Effect of Osocimab in Preventing Venous Thromboembolism Among Patients Undergoing Knee Arthroplasty: The FOXTROT Randomized Clinical Trial. , 2020, JAMA.
[11] Junho Ahn,et al. Thirty-Day Outcomes after Surgery for Primary Sarcomas of the Extremities: An Analysis of the NSQIP Database , 2020, Journal of oncology.
[12] N. Fenwick,et al. International randomised controlled trial for the treatment of newly diagnosed EWING sarcoma family of tumours – EURO EWING 2012 Protocol , 2019, Trials.
[13] H. Schreuder,et al. Bone sarcoma incidence in the Netherlands. , 2019, Cancer epidemiology.
[14] P. Wells,et al. Apixaban to Prevent Venous Thromboembolism in Patients with Cancer , 2019, The New England journal of medicine.
[15] A. Khorana,et al. Rivaroxaban for Thromboprophylaxis in High‐Risk Ambulatory Patients with Cancer , 2019, The New England journal of medicine.
[16] P. Metharom,et al. Cancer-Associated Thrombosis: An Overview of Mechanisms, Risk Factors, and Treatment , 2018, Cancers.
[17] J. Blay,et al. High-Dose Chemotherapy and Blood Autologous Stem-Cell Rescue Compared With Standard Chemotherapy in Localized High-Risk Ewing Sarcoma: Results of Euro-E.W.I.N.G.99 and Ewing-2008. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] Lara A. Kahale,et al. Anticoagulation for people with cancer and central venous catheters. , 2018, The Cochrane database of systematic reviews.
[19] Peter H Shaw,et al. A Comparison of Extremity Thrombosis Rates in Adolescent and Young Adult Versus Younger Pediatric Oncology Patients at a Children's Hospital. , 2017, Journal of adolescent and young adult oncology.
[20] K. S. Hall,et al. Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial , 2016, The Lancet. Oncology.
[21] F. Klok,et al. Current and future perspectives in imaging of venous thromboembolism , 2016, Journal of thrombosis and haemostasis : JTH.
[22] P. Reitsma,et al. Tissue factor associates with survival and regulates tumour progression in osteosarcoma , 2016, Thrombosis and Haemostasis.
[23] S. Schulman,et al. Definition of clinically relevant non‐major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non‐surgical patients: communication from the SSC of the ISTH , 2015, Journal of thrombosis and haemostasis : JTH.
[24] Sybil A. Klaus,et al. Hospital-associated venous thromboembolism in children: incidence and clinical characteristics. , 2014, The Journal of pediatrics.
[25] L. Kremer,et al. Systemic treatments for the prevention of venous thrombo-embolic events in paediatric cancer patients with tunnelled central venous catheters. , 2013, The Cochrane database of systematic reviews.
[26] F. Klok,et al. Diagnostic management of acute deep vein thrombosis and pulmonary embolism , 2013, Journal of thrombosis and haemostasis : JTH.
[27] T. Choueiri,et al. Risk of venous thromboembolism in patients with cancer treated with Cisplatin: a systematic review and meta-analysis. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[28] S. Vesely,et al. Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. , 2012, Chest.
[29] M. Verduijn,et al. The analysis of competing events like cause-specific mortality--beware of the Kaplan-Meier method. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[30] D. Roth,et al. Patient death as a censoring event or competing risk event in models of nursing home placement , 2010, Statistics in medicine.
[31] T. Niazi,et al. Osteosarcoma presenting as hemorrhagic cerebellar metastasis , 2009, Child's Nervous System.
[32] Gary H Lyman,et al. Development and validation of a predictive model for chemotherapy-associated thrombosis. , 2008, Blood.
[33] David M. Thomas,et al. The distinctive biology of cancer in adolescents and young adults , 2008, Nature Reviews Cancer.
[34] Anthony K. C. Chan,et al. Thromboembolism in children with sarcoma , 2007, Pediatric blood & cancer.
[35] L. Helman,et al. Thromboembolic events in children and young adults with pediatric sarcoma. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[36] A. McCaskie,et al. Venous thromboembolism in patients with primary bone or soft-tissue sarcomas. , 2007, The Journal of bone and joint surgery. American volume.
[37] M. Levine,et al. Incidence, risk factors, and outcomes of catheter-related thrombosis in adult patients with cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[38] G. Agnelli,et al. Venous thromboembolism associated with long-term use of central venous catheters in cancer patients. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[39] S. Abraham,et al. Hemorrhagic shock due to intrathoracic rupture of an osteosarcoma of the rib. , 2001, Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia.
[40] K. Antman,et al. Sarcomas of soft tissue and bone , 1991, Cancer.